TY - JOUR
T1 - Survey Reported Participation in Cardiac Rehabilitation and Survival after Mitral or Aortic Valve Surgery
AU - Pack, Quinn R.
AU - Lahr, Brian D.
AU - Squires, Ray W.
AU - Lopez-Jimenez, Francisco
AU - Greason, Kevin L.
AU - Michelena, Hector I.
AU - Goel, Kashish
AU - Thomas, Randal J.
N1 - Funding Information:
The Mayo Clinic Cardiovascular Division funded the survey administration through the Small Grants Program and the statistical analyses through general funds. Survey development was supported by Clinical and Translational Science Award (CTSA) grant TL1 TR000137 from the National Center for Advancing Translational Science . Dr. Pack was supported for manuscript preparation, in part, by the National Center for Advancing Translational Sciences, National Institutes of Health, Award Number KL2TR001063.
Funding Information:
Survey development was supported by Clinical and Translational Science Award (CTSA) grant TL1 TR000137 from the National Center for Advancing Translational Science. Dr. Pack was supported for manuscript preparation, in part, by the National Center for Advancing Translational Sciences, National Institutes of Health, Award Number KL2TR001063.
Publisher Copyright:
© 2016 Elsevier Inc.
PY - 2016/6/15
Y1 - 2016/6/15
N2 - We sought to measure the impact of cardiac rehabilitation (CR) on mortality in patients with mitral or aortic heart valve surgery (HVS) and nonobstructive coronary artery disease. We surveyed all patients (or a close family member if the patient was deceased) who had HVS without coronary artery bypass in 2006 through 2010 at the Mayo Clinic to assess if they attended CR after their HVS. We performed a propensity-adjusted landmark analysis to test the association between CR attendance and long-term all-cause mortality conditional on surviving the first year after HVS. Survey response rate was 40% (573/1,420), with responders more likely to be older, have longer hospitalizations, and have more aortic valve disease. A total of 547 patients (59% aortic surgery, ejection fraction 64%) with valid survey responses and 1-year follow-up were included in the propensity analysis, of whom 296 (54%) attended CR. There were 100 deaths during a median follow-up of 5.8 years. For all patients, the propensity-adjusted model suggested no impact of CR on mortality (hazard ratio [HR] 1.03, 95% CI 0.66 to 1.62). When stratified by procedure, results suggested a potentially favorable, but nonsignificant, effect in patients with mitral valve surgery (HR 0.49, 95% CI 0.15 to 1.56), but not in patients with aortic valve surgery (HR 1.00, 95% CI 0.61 to 1.64.) In conclusion, we found no survival advantage for patients with normal preoperative ejection fraction who attended CR after surgical "correction" of their severe aortic or mitral valve disease.
AB - We sought to measure the impact of cardiac rehabilitation (CR) on mortality in patients with mitral or aortic heart valve surgery (HVS) and nonobstructive coronary artery disease. We surveyed all patients (or a close family member if the patient was deceased) who had HVS without coronary artery bypass in 2006 through 2010 at the Mayo Clinic to assess if they attended CR after their HVS. We performed a propensity-adjusted landmark analysis to test the association between CR attendance and long-term all-cause mortality conditional on surviving the first year after HVS. Survey response rate was 40% (573/1,420), with responders more likely to be older, have longer hospitalizations, and have more aortic valve disease. A total of 547 patients (59% aortic surgery, ejection fraction 64%) with valid survey responses and 1-year follow-up were included in the propensity analysis, of whom 296 (54%) attended CR. There were 100 deaths during a median follow-up of 5.8 years. For all patients, the propensity-adjusted model suggested no impact of CR on mortality (hazard ratio [HR] 1.03, 95% CI 0.66 to 1.62). When stratified by procedure, results suggested a potentially favorable, but nonsignificant, effect in patients with mitral valve surgery (HR 0.49, 95% CI 0.15 to 1.56), but not in patients with aortic valve surgery (HR 1.00, 95% CI 0.61 to 1.64.) In conclusion, we found no survival advantage for patients with normal preoperative ejection fraction who attended CR after surgical "correction" of their severe aortic or mitral valve disease.
UR - http://www.scopus.com/inward/record.url?scp=84964689313&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84964689313&partnerID=8YFLogxK
U2 - 10.1016/j.amjcard.2016.03.052
DO - 10.1016/j.amjcard.2016.03.052
M3 - Article
C2 - 27138188
AN - SCOPUS:84964689313
SN - 0002-9149
VL - 117
SP - 1985
EP - 1991
JO - American Journal of Cardiology
JF - American Journal of Cardiology
IS - 12
ER -